menu

Supporting research leaders at all career stages

The Novo Nordisk Foundation Research Leader Programme aims to ensure that excellent research leaders have the opportunity to pursue ambitious and innovative projects.

Latest news

The Novo Nordisk Foundation awards DKK 413 million to 44 research leaders at different stages of their careers

The Novo Nordisk Foundation’s new Research Leader Programme gives researchers the opportunity to pursue ambitious projects, solve complicated problems and develop new techniques and methods. The Programme also aims to support the continuing development of top researchers.

The Novo Nordisk Foundation has awarded 44 grants of up to DKK 10 million each to outstanding research leaders at different stages of their careers at universities, hospitals and other research institutions throughout Denmark and in the other Nordic countries. The grants, which last 5 years, will enable these researchers..

Meet our recipients

Project examples

DKK 2.4 billion over 5 years

The Novo Nordisk Foundation has allocated DKK 2.4 billion (€322 million) for its Research Leader Programme aimed at excellent research leaders at different stages of their careers.

Up to 48 grants of up to DKK 10 million each are awarded each year. The 5-year grants are awarded within four scientific fields:

  • endocrinology and metabolic research;
  • biotechnology-based synthesis and production research;
  • clinical and translational research; and
  • bioscience and basic biomedical research.

The grants are awarded based on applications submitted in open competition. Calls for applications are typically open in late fall with deadlines in January. 

See all Novo Nordisk Foundation calls here. 

 

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close